The Chimeric Genes AML1/MDS1 and AML1/EAP Inhibit AML1B Activation at the CSF1R Promoter, but Only AML1/MDS1 Has Tumor-Promoter Properties.

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.93.3.1044
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Targeted Degradation of the AML1/MDS1/EVI1 Oncoprotein by Arsenic Trioxide

Cancer Research
Cancer ResearchOncology
2006English

AML1 (Acute Myeloid Leukemia 1)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2010English

Three Distinct Domains in TEL-AML1 Are Required for Transcriptional Repression of the IL-3 Promoter

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

AML1 (CBFα2) Cooperates With B Cell-Specific Activating Protein (BSAP/PAX5) in Activation of the B Cell-specificBLKGene Promoter

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

CCAAT Enhancer-Binding Protein (C/Ebp) and AML1 (CBF Alpha2) Synergistically Activate the Macrophage Colony-Stimulating Factor Receptor Promoter.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1996English

Epigenetic Consequences of AML1-ETO Action at the Human C-FMS Locus

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2003English

Significance of the TEL-AML1 Fusion Gene in Childhood AML

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

ETO, but Not Leukemogenic Fusion Protein AML1/ETO, Augments RBP-J /SHARP-Mediated Repression of Notch Target Genes

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2008English

Acute Myeloid Leukemia With T(3;21)(q26.2;q22) Developing Following Low‑dose Methotrexate Therapy for Rheumatoid Arthritis and Expressing Two AML1/MDS1/EVI1 Fusion Proteins: A Case Report

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy